Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.
Halleck F, Böhmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sjöholm K, Runström A, Lefèvre P, Tollemar J, Jordan S. Halleck F, et al. Among authors: jordan s. Clin Transplant. 2024 Jul;38(7):e15383. doi: 10.1111/ctr.15383. Clin Transplant. 2024. PMID: 39023092 Clinical Trial.
National conference to assess antibody-mediated rejection in solid organ transplantation.
Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL. Takemoto SK, et al. Among authors: jordan s. Am J Transplant. 2004 Jul;4(7):1033-41. doi: 10.1111/j.1600-6143.2004.00500.x. Am J Transplant. 2004. PMID: 15196059 Free article.
Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols.
Montgomery RA, Hardy MA, Jordan SC, Racusen LC, Ratner LE, Tyan DB, Zachary AA; Antibody Working Group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Montgomery RA, et al. Transplantation. 2004 Jul 27;78(2):181-5. doi: 10.1097/01.tp.0000129256.84027.d6. Transplantation. 2004. PMID: 15280674 Review.
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee. Haas M, et al. Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Am J Transplant. 2014. PMID: 24472190 Free article.
2,258 results